InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,436.70
(
-1.55%
)
US TECH 100
18,416.80
(
-2.26%
)
Dow Jones
40,247.20
(
-1.46%
)
Brent Oil
80.00
(
-1.86%
)
Bitcoin
62,521.40
(
-3.21%
)
Post# of 466081
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Rubyred77

Send PM Follow Ignore
Followers 15
Posts 1361
Boards Moderated 0
Alias Born 07/27/2015

Rubyred77

Re: XenaLives post# 95336

Monday, 03/13/2017 8:58:00 PM

Monday, March 13, 2017 8:58:00 PM

Post# of 466081
I think they are trying to rush through the trial so they can sell to the highest bidder. No other reason why a p2 trial for Alzheimer's would only last for 3 months. Saying it's to help patients live longer sounds like bs IMO. I'm out of my little position for NTRP before the uplisting happens. Lol
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM

Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM

VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM

Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM

Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM

Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!